Fund BasicsSee More
- Fund Family Harbor Funds
- Assets Under Management 4,601,400
- Shares Outstanding, K 200
- 60-Month Beta 1.00
- Price/Earnings ttm 36.40
- Annual Dividend & Yield 0.00 (0.00%)
- Most Recent Dividend N/A on N/A
- Management Fee 0.80%
|Period||Period Low||Period High||Performance|
| || |
+1.78 (+8.28%)since 11/01/23
| || |
+0.83 (+3.71%)since 09/01/23
| || |
+2.41 (+11.52%)since 12/01/22
UnitedHealth Group reported better-than-expected first-quarter 2023 results, breezing past the Zacks Consensus Estimate for earnings and revenues.
UnitedHealth Group (UNH) breezed past the Zacks Consensus Estimate for earnings.
Ms. Dolphin is a key strategic addition to the team, and will have an impact on the corporate strategy and growth opportunities of the company...
As we build upon the three core pillars of our success, Drug Development, Digital Therapeutics, and our North American Clinical Network, we are focused on...
Mr. Zimaro is another key strategic addition to the team, and will have an impact on the corporate strategy and growth opportunities of the company...
Dr. Hilmas will Represent the Company at the IPA World Congress and Probiota Americas Event Organized by William Reed Ltd. ...
VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF)...
The Company’s Ottawa-Based IRP Health Clinic has Also Been Approved by Veterans Affairs Canada for its Reactivation Program...
The Company’s Wholly-Owned Contract Research Organization has Recently Signed a Number of New Contracts, Completed Clinical Research Reports and Obtained...
The Company’s Mission is Now to Enrich Lives Through Enhanced Mental Health Services via its Core Pillars of Contract Research, Treatment Clinics and...
|3rd Resistance Point||23.37|
|2nd Resistance Point||23.33|
|1st Resistance Point||23.31|
|1st Support Level||23.24|
|2nd Support Level||23.20|
|3rd Support Level||23.18|